4//SEC Filing
Tasker Sybil 4
Accession 0001012975-18-000459
CIK 0001326190other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:26 PM ET
Size
5.5 KB
Accession
0001012975-18-000459
Insider Transaction Report
Form 4
Tasker Sybil
Chief Medical Officer
Transactions
- Award
Stock Options (option to buy)
2018-05-21+50,016→ 50,016 totalExercise: $0.45Exp: 2028-05-21→ Common Stock, par value $0.0001 (50,016 underlying)
Footnotes (1)
- [F1]Twenty-five percent of the option becomes vested and exercisable on March 1, 2019, and the aggregate unvested remaining portion will vest and become exercisable in equal monthly installments on the first day of each month over the 36-month period starting April 1, 2019.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001705900
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 5:26 PM ET
- Size
- 5.5 KB